- Home
- CVRX vs OPP Comparison
CVRX vs OPP Comparison
Compare CVRX & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- OPP
- Stock Information
- Founded
- CVRX 2000
- OPP 2010
- Country
- CVRX United States
- OPP United States
- Employees
- CVRX N/A
- OPP N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- OPP Finance/Investors Services
- Sector
- CVRX Health Care
- OPP Finance
- Exchange
- CVRX Nasdaq
- OPP Nasdaq
- Market Cap
- CVRX 203.9M
- OPP 208.6M
- IPO Year
- CVRX 2021
- OPP N/A
- Fundamental
- Price
- CVRX $7.87
- OPP $8.78
- Analyst Decision
- CVRX Buy
- OPP
- Analyst Count
- CVRX 7
- OPP 0
- Target Price
- CVRX $14.00
- OPP N/A
- AVG Volume (30 Days)
- CVRX 177.7K
- OPP 108.0K
- Earning Date
- CVRX 10-28-2025
- OPP 01-01-0001
- Dividend Yield
- CVRX N/A
- OPP 14.41%
- EPS Growth
- CVRX N/A
- OPP N/A
- EPS
- CVRX N/A
- OPP N/A
- Revenue
- CVRX $54,652,000.00
- OPP N/A
- Revenue This Year
- CVRX $11.32
- OPP N/A
- Revenue Next Year
- CVRX $18.58
- OPP N/A
- P/E Ratio
- CVRX N/A
- OPP N/A
- Revenue Growth
- CVRX 23.11
- OPP N/A
- 52 Week Low
- CVRX $4.30
- OPP $7.26
- 52 Week High
- CVRX $18.55
- OPP $8.83
- Technical
- Relative Strength Index (RSI)
- CVRX 53.22
- OPP 66.05
- Support Level
- CVRX $7.22
- OPP $8.70
- Resistance Level
- CVRX $8.35
- OPP $8.78
- Average True Range (ATR)
- CVRX 0.38
- OPP 0.07
- MACD
- CVRX 0.03
- OPP 0.01
- Stochastic Oscillator
- CVRX 57.52
- OPP 87.32
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.
RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.